Tirnovetmab
Based on 1 Customer Validation
Tirnovetmab (KIND-016) is an anti-IL-31 monoclonal antibody. Tirnovetmab ameliorates canine allergic dermatitis and atopic dermatitis. Tirnovetmab can be used in research on canine allergic and atopic dermatitis.
For research use only. We do not sell to patients.
- Purity : 99.97%
- CAS No.: 2364504-80-1
- Molecular Weight:148.58 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Canine IgG2 kappa
Recommend Isotype Controls
Species Reactivity
Canine
IC50 & Target
[1]|
IL-31 |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
256353430 [NCBI]
Accession
BAH97742
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG2-kappa
Application
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 2364504-80-1
-
Appearance Liquid
-
Molecular Weight 148.58 kDa
-
Color Colorless to light yellow
-
SMILES
[Tirnovetmab]
-
Synonyms
KIND-016
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
TPA/Croton Oil Ear Edema and Dermatitis
The TPA (12-O-tetradecanoylphorbol-13-acetate) and croton oil-induced mouse ear edema model is a well-established acute cutaneous inflammation system used to evaluate topical anti-inflammatory activity by measuring edema formation, neutrophil infiltration, vascular permeability, and cytokine-mediated skin responses in vivo. The inflammatory response is triggered by topical application of phorbol esters (TPA) or croton oil constituents, leading to rapid activation of protein kinase C signaling, leukocyte recruitment, and increased vascular permeability, which can be quantified by ear thickness, weight, dye extravasation, and biochemical markers such as myeloperoxidase (MPO) activity and pro-inflammatory mediators in ear tissue homogenates. This model is widely used for screening anti-inflammatory agents, where reductions in edema and inflammatory biomarkers reflect suppression of acute dermal inflammation and immune cell infiltration. Histological evaluation typically confirms epidermal
Purity & Documentation
-
Data Sheet (264 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)